SCHEMBL6475699

SCHEMBL6475699

CC(C)(N)c1ccc(CO)nc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 1/20 0.38
PI4KA P42356 1/20 0.38
PI4KB Q9UBF8 1/20 0.38
KMT2A Q03164 1/20 0.37
PDE2A O00408 1/20 0.34
CDK1 P06493 2/20 0.33
KDR P35968 2/20 0.33
CCR1 P32246 1/20 0.33
SMO Q99835 1/20 0.33
NOTUM Q6P988 1/20 0.33
MBOAT4 Q96T53 2/20 0.32
AKT1 P31749 1/20 0.32
AKT2 P31751 1/20 0.32
KLF10 Q13118 1/20 0.32
DAO P14920 1/20 0.31
DGAT1 O75907 1/20 0.31
S1PR1 P21453 1/20 0.31
PPARG P37231 1/20 0.30
PPARD Q03181 1/20 0.30
PPARA Q07869 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2739659 0.84 LMNA (0.38) PIK3CAPI4KAPI4KBKMT2ACCR1
SCHEMBL3235456 0.82 PDE2A (0.35) KMT2APDE2ASMOMBOAT4AKT1
SCHEMBL472531 0.80 KMT2A (0.52) KMT2APDE2ANOTUMMBOAT4DAO
SCHEMBL22778750 0.79 ESR1 (0.37) PIK3CAPI4KAPI4KBCCR1KLF10
Hydrochloric Acid SCHEMBL3565805 0.78 KMT2A (0.50) KMT2APDE2ANOTUMMBOAT4DAO
SCHEMBL29694761 0.78 S1PR1 (0.32) PIK3CAPI4KAPI4KBCCR1KLF10
SCHEMBL29108132 0.78 S1PR1 (0.32) PIK3CAPI4KAPI4KBCCR1KLF10
SCHEMBL29108421 0.77 MTOR (0.34) PIK3CAPI4KAPI4KBCCR1SCN10A
SCHEMBL6481334 0.74 LMNA (0.34) PDE2ASMOMBOAT4
SCHEMBL11971888 0.74 PDE2A (0.38) KMT2APDE2ACDK1KDRSMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6900209-B2 Nitrogen substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives for enhancing cognition MERCK SHARP & DOHME LTD. 2005-05-31 US claimed
US-20040043982-A1 Nitrogen substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives for enhancing cognition MERCK SHARP & DOHME LTD. (GB) 2004-03-04 US claimed
US-6900209-B2 Nitrogen substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives for enhancing cognition MERCK SHARP & DOHME LTD. 2005-05-31 US disclosed
US-20040043982-A1 Nitrogen substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives for enhancing cognition MERCK SHARP & DOHME LTD. (GB) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040043982-A1 Nitrogen substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives for enhancing cognition PSEN1, BDNF, H1-5 PIK3CA 2116/4885PI4KA 1650/4885PI4KB 2856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.